AI Article Synopsis

  • Tietze syndrome is a rare condition causing chest pain and joint swelling, with no standard treatment, prompting a study on the efficacy of oral steroids combined with NSAIDs for relief and improved quality of life.
  • In this study, 40 patients were split into two groups: one received oral steroids plus NSAIDs while the other only got NSAIDs, with pain and symptoms assessed over three weeks and evaluated for long-term effects.
  • Results showed that the steroid group experienced significantly greater pain relief and improvement in quality of life compared to the NSAID-only group, with minimal side effects reported.

Article Abstract

What Is Known And Objective: Tietze syndrome is a rare form of chest wall costochondritis with joint swelling which can cause significant chest pain and decline in ability of daily activities. There is no standardized treatment protocol. The aim of this study was to assess the efficacy of adding oral steroids in addition to other non- steroidal treatment in improvement of pain and quality of life (QOL) in patients with Tietze syndrome.

Methods: Forty patients with Tietze syndrome were randomly divided into two treatment groups: (1) One week of prednisolone 40 mg daily followed by 1 week of prednisolone 20 mg daily followed by 1 week of 10 mg with 3 weeks of non-steroidal anti-inflammatory drug (NSAID) treatment (n = 20); (2) three weeks of NSAID treatment only (n = 20). A symptom questionnaire was used to rate the major symptoms of Tietze syndrome and costochondritis: Numeric rating scale (NRS) for pain on a scale of 0 (no pain) to 10 (severest pain); the resulting global symptom score was used to evaluate the efficacy of treatment with assessment of joint swelling resolution. The EQ-5D-5L instrument for measurement of QOL was used. Assessments were made on intention to treat basis at baseline and at 1, 2 and 3 weeks followed by a medium term follow period after treatment cessation. The trial was registered at www.isrctn.com ISRCTN11877533.

Results And Discussion: There was a significant drop in mean NRS pain scores between the groups at 1, 2 and 3 weeks in favour of the steroid group (46.8% vs. 17.7%; p < 0.001, 56.3% vs. 35.8% p < 0.001 and 65.4% vs. 46.7% p < 0.001 respectively). There was a 25.8% (95% CI 13.2-38.8) difference in mean NRS score drop at a median of 6.5 months after treatment cessation in favour of the steroid group over the NSAID only group. Only three cases of mild GIT upset in the steroid group and two cases of mild nausea were reported in the NSAID group. There was an improvement in QOL using the median EQ-5D-5L scoring at 3 weeks in favour of the steroid group 7 (7, 8) versus 10 (8.5-11), (p < 0.001). The improvement in pain scoring and QOL did not correlate with improvement in joint swelling at 3 weeks after treatment with 2/20 (10%) in the steroid arm versus 1/20 (5%) in NSAID arm having an obvious improvement (p = 0.393).

What Is New And Conclusion: In this study, addition of short-term oral corticosteroids showed a clear benefit for use at 1, 2 and 3 weeks in improvement of pain and QOL in patients with Tietze syndrome. This difference was maintained at mid-term follow up after treatment cessation. This facilitates the advantage of using steroids as well as excluding their side effects for an accepted timeframe.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcpt.13810DOI Listing

Publication Analysis

Top Keywords

tietze syndrome
16
treatment
8
joint swelling
8
patients tietze
8
daily 1 week
8
nsaid treatment
8
treatment n = 20
8
nrs pain
8
pain
6
tietze
5

Similar Publications

Spondyloarthritis and Tietze's syndrome: A Re-evaluation.

Mod Rheumatol

September 2024

Division of Clinical Rheumatology, Sakurajyuji Hospital, Kumamoto, Japan.

Article Synopsis
  • * These conditions can be difficult to differentiate from other rheumatic diseases due to similar symptoms, particularly swelling in the chest area, which can resemble Tietze's syndrome.
  • * The article emphasizes the need for careful diagnosis between spondyloarthritis and Tietze's syndrome, as accurate identification is crucial for effective treatment.
View Article and Find Full Text PDF

Leucine aminoacyl tRNA-synthetase 1 (LARS1)-deficiency (infantile liver failure syndrome type 1 (ILFS1)) has a multisystemic phenotype including fever-associated acute liver failure (ALF), chronic neurologic abnormalities, and encephalopathic episodes. In order to better characterize encephalopathic episodes and MRI changes, 35 cranial MRIs from 13 individuals with LARS1 deficiency were systematically assessed and neurological phenotype was analyzed. All individuals had developmental delay and 10/13 had seizures.

View Article and Find Full Text PDF

Tietze syndrome is a relatively uncommon condition characterized by painful swelling localized in the costo-sternal, sternoclavicular, or costochondral joints. Despite its benign nature, Tietze syndrome can mimic more serious conditions, necessitating thorough evaluation and exclusion of differential diagnoses. Management typically involves non-steroidal anti-inflammatory drugs and corticosteroid therapy, with surgical intervention reserved for refractory cases.

View Article and Find Full Text PDF

Introduction: Autism spectrum disorder (ASD) is a neurodevelopmental disorder that persists into adulthood with both social and cognitive disturbances. Asperger's syndrome (AS) was a distinguished subcategory of autism in the DSM-IV-TR defined by specific symptoms including difficulties in social interactions, inflexible thinking patterns, and repetitive behaviour without any delay in language or cognitive development. Studying the functional brain organization of individuals with these specific symptoms may help to better understand Autism spectrum symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!